Revenue reached $9.7 billion, up 14% from a year earlier, while annualized revenue run-rate surged 63% to $3.2 billion as ...

When the College Board cancelled SAT testing in 2020, hundreds of colleges adopted test-optional admissions policies for that fall. The Urban Institute reported that the number of four-year colleges a ...

House and Senate Republicans say they have a “front row seat to a train wreck” next month as the Legislature prepares to fill ...

Significant reduction in key neurodegeneration biomarker correlated with treatment response, suggesting neflamapimod may act on underlying disease CervoMed preparing to initiate Phase 3 registrational ...

GBA develops ward reservation roster for civic polls amid OBC activists' concerns over non-implementation of Supreme Court’s ‘triple test’.

Iren Ltd. (NASDAQ:IREN) moved into the spotlight with a financing play that could reshape how investors think about the ...

Anavex Life Sciences' Phase 2B/3 trial failed to achieve statistical significance on both primary endpoints. Read why I ...

Nvidia and Synopsys, which announced their expanded partnership Monday, are among the global players in the AI semiconductor ...

The FDA has cleared Neurosense to begin its pivotal Phase 3 clinical trial of PrimeC for the treatment of amyotrophic lateral ...

Data demonstrates neflamapimod treatment led to significant reductions in plasma glial fibrillary acidic protein ( GFAP), a key marker of neuroinflammation-associated neurodegeneration, and increased ...

Nvidia Corp. has bought a $2 billion stake in Synopsys Inc. as part of a new multi-year partnership the companies announced ...